semaglutide cancer cases GLP-1 drugs may be linked to a lower risk of progression, according to new research that will be presented next week at the American Society of Clinical Oncology's annual meeting Are GLP-1 drugs (Ozempic/Zepbound) affecting

Retatrutide is a new type of weight-loss medication which is currently undergoing clinical trials by Eli Lilly, but is not yet approved for use either in the US or UK

Among them, dimethyl biguanide (known as metformin) was selected for clinical development with the suggestive name of Glucophage, which means glucose eater. The other biguanides, phenformin and buformin, were more potent than metformin, however in the late 1970s they were removed in most countries because of their association with lactic acidosis (Kathuria et al., 2021)

There are a lot of questions about these meds: how they compare, which might work better, and which is the safest

the normal rates are 630 M/hr, 273 M/hr and 70 M/hr, respectively